Tripcit-BRD Tablets

Class : Trypsin and Bromelain belongs to the class of naturally occuring systemic enzymes and Rutoside Trihydrate is a phytonutrient. Diclofenac belongs to the class of non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions.
Indication
OBETRA-D Tablets can be used in the treatment of following conditions :

• Post-operative pain.
• Edema and inflammation in contusions, lacerations, cuts, sinusitis, otitis, externa, PID (Pelvic inflammatory disease), tooth extraction, cellulitis, abscess, sport injuries, sprains and surgery.
• Painful osteoarthritis, rheumatoid arthritis, spondylopathies, tendonitis, polymyositis, dermatomyositis and gout.
• Pain management of kidney stones and gallstones, chronic pain in cancer, post-traumatic pain, dysmenorrhea and acute migraines.
• Temporary relief from aches, pains and muscle soreness due to everyday activity.

Dosage : One OBETRA-D Tablet three times a day or as directed by Physician.
Mechanism of action : Trypsin and Bromelain are proteolytic enzymes. They break peptide bond inside protein molecules. Bromelain exerts anti-inflammatory activity by affecting prostaglandin synthesis. Rutoside is a glycoside and has antioxidant effect. It increases the strength of the walls of the blood capillaries and regulates their permeability. Diclofenac inhibit both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis.